HA
MRK icon

Harfst & Associates’s Merck MRK Stock Holding History

Harfst & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,138
Closed -$282K – 112
2025
Q1 		$282K Sell
3,138
-425
-12% -$39.7K 0.07% 108
2024
Q4 		$354K Sell
3,563
-1,911
-35% -$197K 0.07% 71
2024
Q3 		$622K Sell
5,474
-771
-12% -$91.6K 0.14% 68
2024
Q2 		$773K Sell
6,245
-466
-7% -$60K 0.18% 69
2024
Q1 		$885K Sell
6,711
-9,255
-58% -$1.14M 0.21% 65
2023
Q4 		$1.74M Sell
15,966
-137
-0.9% -$14.2K 0.46% 52
2023
Q3 		$1.66M Sell
16,103
-68
-0.4% -$7.33K 0.47% 57
2023
Q2 		$1.87M Buy
16,171
+11,524
+248% +$1.31M 0.5% 55
2023
Q1 		$494K Sell
4,647
-25
-0.5% -$2.7K 0.14% 89
2022
Q4 		$518K Sell
4,672
-145
-3% -$14.8K 0.15% 88
2022
Q3 		$415K Buy
4,817
+628
+15% +$56.1K 0.12% 92
2022
Q2 		$381K Buy
4,189
+5
+0.1% +$443 0.11% 97
2022
Q1 		$343K Sell
4,184
-195
-4% -$15.4K 0.08% 105
2021
Q4 		$335K Hold
4,379
– – 0.09% 101
2021
Q3 		$328K Sell
4,379
-66
-1% -$5.02K 0.09% 107
2021
Q2 		$345K Sell
4,445
-2,945
-40% -$219K 0.1% 109
2021
Q1 		$543K Sell
7,390
-1,896
-20% -$140K 0.16% 102
2020
Q4 		$724K Buy
+9,286
New +$710K 0.27% 67
2017
Q2 		– Sell
-3,371
Closed -$204K – 269
2017
Q1 		$204K Buy
+3,371
New +$205K 0.09% 71
2016
Q3 		– Sell
-30,981
Closed -$1.7M – 90
2016
Q2 		$1.7M Buy
+30,981
New +$1.65M 0.69% 35
2016
Q1 		– Sell
-30,354
Closed -$1.53M – 177
2015
Q4 		$1.53M Sell
30,354
-137
-0.4% -$6.91K 0.62% 34
2015
Q3 		$1.44M Buy
30,491
+27,037
+783% +$1.44M 0.63% 41
2015
Q2 		$188K Buy
+3,454
New +$194K 0.11% 75

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harfst & Associates's MRK Position: Q2 2025 in Review

Harfst & Associates sold out of Merck (MRK) in Q2 2025, closing a stake of 3,138 shares — an estimated $282K sold.

Harfst & Associates first reported a position in MRK in Q2 2015 and held it in 23 quarters. The position peaked at $1.87M in Q2 2023. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Harfst & Associates reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Harfst & Associates sold 3,138 Merck shares in Q2 2025, an estimated $282K.
  • Harfst & Associates first reported a position in Merck in Q2 2015 and held it in 23 quarters.
  • Harfst & Associates's Merck position peaked at $1.87M in Q2 2023.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Harfst & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.